Electroacupuncture for mild to moderate high blood pressure
Tests electroacupuncture on blood pressure in people with mild to moderate hypertension.
Key facts
- Who runs it
- University of California, Irvine
- Where
- Irvine and Orange, United StatesSee the 2 sites
- Trial code
- Registry title
- Acupuncture Therapy and Hypertension
- Status
- Recruiting
- People taking part
- 72 people, planned
- Started
- 1 Jan 2023
- Expected to end
- 31 Mar 2027
- Type of study
- Interventional, 4 groups
- Treatments tested
- electroacupuncture
- Record updated
- 20 July 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with mild to moderate high blood pressure, whether or not they take blood pressure medicine. Participants get electroacupuncture (acupuncture with a small electric current) once a week for 8 weeks.
- Age
- 45 to 75 years
- Sex
- All sexes can join.
- Disease stage
- Mild to moderate high blood pressure diagnosed by a doctor. Office upper (systolic) blood pressure must be > 140 mmHg and < 160 mmHg. Or the average upper reading from a portable blood pressure monitor (ABPM) must be > 130 mmHg and < 145 mmHg.
- Earlier treatment
- People can join whether or not they take blood pressure medicine.
- Biomarker or test result
- The heart tracing (ECG) at rest must show no significant signs of poor blood flow to the heart (no ST elevation or depression).
Main reasons for not taking part
- Pregnant or breastfeeding.
- Heart artery disease, left bundle branch block on ECG, or heart rhythm problems with low blood pressure (<90 mmHg).
- Severe high blood pressure (BP >170 mmHg systolic or >110 mmHg diastolic).
- Disease of the blood vessels in the limbs, bone or joint disease, nerve damage from diabetes, or any other physical or mental illness.
- Known sensitivity to skin preparations, medical dressings or skin tapes, or unable or unwilling to give written consent.
The registry criteria, word for word
Show all 7 criteriaShow less
Who can take part
- Subjects from 45 to 75 years of age
- Clinically diagnosed with mild to moderate hypertension and ON or OFF medication (Office SBP > 140 mmHg and < 160 mmHg Or ABPM average SBP > 130 mmHg and < 145 mmHg), and
- No significant ECG change reflecting ischemia (i.e. ST elevation or depression) at rest will be recruited to participate in this study
Who cannot take part
- Subjects will be excluded if they have coronary disease (by history or on ECG screening), conduction abnormalities on ECG consistent with left bundle branch block, cardiac arrhythmias associated with low blood pressure (<90 mmHg), peripheral vascular disease, orthopedic disease, diabetic neuropathy or severe hypertension (BP >170 mmHg systolic or >110 mmHg diastolic), or any other physical or psychological illness
- Subjects will be excluded if pregnant or nursing
- Those with known sensitivity to any topical preparations or strong reactions to medical dressings and skin tapes also will be excluded
- Inability our or unwillingness of individual to give written informed consent
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 45 and 75 years old?
Where in United States
- Susan Samueli Integrative Health InstituteIrvine, United StatesContact: Mitchell Beasley, MD, PhD, MPHTaking people
- University of California, Irvine, Health Sciences Medical CenterOrange, United StatesContact: Herlinda Bergman, M.Sc.Taking people
About the trial
What the trial wants to find out
Acupuncture therapy will be provided to reduce blood pressure in hypertensive patients. The mild to moderate hypertensive patients will be either on or off hypertensive medications. The course last for 8 weeks and the frequency is once a week.
The 4 groups in the trial
- Anti-inflammatory EA (AI-EA)Treatment being tested
Anti-inflammatory electroacupuncture therapy
Treatment: electroacupuncture
- Sympathoinhibitory EA (SI-EA)Treatment being tested
sympatho-inhibitory electroacupuncture therapy
Treatment: electroacupuncture
- Combined EA (cEA)Treatment being tested
combination of SI-EA and AI-EA
Treatment: electroacupuncture
- Control EA (Sham-EA)Treatment being tested
Sham electroacupuncture
Treatment: electroacupuncture
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Neuroimmune Mechanisms Underlying Electroacupuncture Effect on Vascular Function
- Plain-language title
- Electroacupuncture for mild to moderate high blood pressureGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT05530512, who can take part
- Record updated
- 20 July 2025